MANHATTAN SCIENTIFICS, INC
OTC
US Flag
MHTX

MHTX
MANHATTAN SCIENTIFICS, INC
US Flag
OTC
 
Next Earning
Market Cap
EPS
Div Yield
P/E
Next Earning
Market Cap
EPS
Div Yield
P/E

MHTX Stock Chart

Financials

Valuation
Enterprise Value/EBITDA, TTM
Enterprise Value, FQ
Market Cap — Basic
Number of Employees
Number of Shareholders
Price/Earnings, TTM
Price/Revenue, TTM
Price/Book Ratio, FY
Price/Sales Ratio, FY
Balance Sheet
Current Ratio, FQ
Debt to Equity, FQ
Net Debt, FQ
Quick Ratio, FQ
Total Assets, FQ
Total Debt, FQ
Operating Metrics
Return on Assets, TTM
Return on Equity, TTM
Return on Invested Capital, TTM
Revenue per Employee, TTM
Price History
Average Volume (10 day)
Beta - 1 Year
Price - 52 Week High
Price - 52 Week Low
Dividends
Dividends Paid, FY
Dividends per Share, FY
Expected Annual Dividends
Dividends Yield
Margins
Net Margin, TTM
Gross Margin, TTM
Operating Margin, TTM
Pretax Margin, TTM
Income Statement
Basic EPS, Net Income
Earnings per Share, Basic, TTM
EBITDA, TTM
Gross Profit, FY
Last Annual EPS
Last Annual Revenue, FY
Net Income, FY
Total Revenue, FY
Free Cash Flow, TTM

Profile

Sector: Healthcare
Industry: Biotechnology & Medical Research
Employees: 11
Manhattan Scientifics, Inc. operates as a technology incubator that seeks to acquire, develop and commercialize technologies in various fields, with emphasis in the areas of nanotechnology. The Company is focused on technology transfer and commercialization of transformative technologies in the nano medicine space. The Company has two subsidiaries, both focused on nanotechnology applications in medicine: Metallicum, Inc. and Senior Scientific LLC. The Company's bioimaging and nanomagnetic detection systems have been developed to detect cancer and other diseases earlier and with specificity. It has developed hardware and software for the sensitive detection of nanomagnetic particles that can be linked to antibodies for the detection and treatment of cancer and other human diseases, all without the use of ionizing radiation or large magnetic fields. Its technologies make possible the earlier detection of cancer in vivo, and the ability to analyze biopsies with sensitivity.

News

Home Stock Screener Forex Screener Crypto Screener Economic Calendar Shows How It Works Chart Features Pricing House Rules Moderators Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Help Center Refer a friend Feature Request Blog & News FAQ Wiki Twitter
Profile Profile Settings Account and Billing Refer a friend My Support Tickets Help Center Ideas Published Followers Following Private Messages Chat Sign Out